Ferda Öner Erkekol

Ferda Öner Erkekol

Auto-generated profile, based on publicly available information

Ferda Öner Erkekol

Clinic of Immunology and Allergic Diseases, Ankara Yildirim Beyazit University, Faculty of Medicine, Ankara City Hospital

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2021 in Allergy
Verified
Journal Article
Closed access
PDF file
Ibon Eguíluz-GraciaIbon Eguíluz-Gracia
Ibon Eguíluz-Gracia
MBMaarten van Den Berge
Maarten van Den Berge
CBCristina Boccabella
Cristina Boccabella
MBMatteo Bonini
Matteo Bonini
CCCristiano Caruso
Cristiano Caruso
IAIoana Agache
Ioana Agache

31 May 2023 in Journal of Asthma
Verified
Journal Article
Closed access
GCGulfem Elif Celik
Gulfem Elif Celik
OAOmur Aydin
Omur Aydin
DGDerya Gökmen
Derya Gökmen
GBGozde Koycu Buhari
Gozde Koycu Buhari
ZSZeynep Celebi Sözener
Zeynep Celebi Sözener
AYArzu Yorgancioglu
Arzu Yorgancioglu
National data on asthma characteristics and the factors associated with uncontrolled asthma seem to be necessary for every country. For this purpose, we developed the Turkish Adult Asthma Registry ...

1 September 2006 in Annals of Allergy, Asthma & Immunology
Verified
Journal Article
Closed access
FEFerda Öner Erkekol
Ferda Öner Erkekol
GÇGülfem E. Çelik
Gülfem E. Çelik
ÖKÖzlem Keskin
Özlem Keskin
EGEmine Güllü
Emine Güllü
DMDilşad Mungan
Dilşad Mungan
ZMZeynep Mısırlıgil
Zeynep Mısırlıgil

1 September 2023 in Allergologia et Immunopathologia
Verified
Journal Article
Open access
PDF file
PÇPamir Çerçi
Pamir Çerçi
RKResat Kendirlinan
Resat Kendirlinan
SBSuna Büyüköztürk
Suna Büyüköztürk
AGAslı Gelincik
Aslı Gelincik
DÜDerya Ünal
Derya Ünal
SBSevim Bavbek
Sevim Bavbek
Background: Hypersensitivity reactions (HSRs) to nonsteroidal anti-inflammatory drugs (NSAIDs) are a significant clinical issue. Several classifications have been proposed to categorize these reactions, including the current European Academy of Allergy and Clinical Immunology/ European Network for Drug Allergy (EAACI/ENDA) classification. This study aimed to evaluate the applicability of this classification in a real-world clinical setting. Methods: We conducted a national multicenter study involving patients from nine hospitals in four major urban centers in Turkey. All patients had a suggestive clinical history of hypersen-sitivity reactions to NSAIDs. Researchers collected data using a structured form and classified reactions based on the EAACI/ENDA classification. Oral provocation tests with several NSAIDs were performed using a single-blind challenge per EAACI/ENDA guidelines. Results: Our retrospective study included 966 adult patients with a history of hypersensitivity to NSAIDs. The most common triggers were Acetylsalicylic Acid (ASA), paracetamol, and metamizole. The most prevalent acute NSAID hypersensitivity group was NSAID-induced urticaria/angioedema (NIUA) (34.3%). However, 17.3% of patients did not fit neatly into the current EAACI/ENDA classification. Notably, patients with underlying asthma or allergic rhinoconjunctivitis exhibited unusual reactions, such as urticaria and/or angioedema induced by multiple chemical groups of NSAIDs, blended mixed reactions, and isolated periorbital angioedema in response to multiple chemical groups of NSAIDs. Conclusions: While the EAACI/ENDA classification system stratifies NSAID-induced hypersensitivity reactions into five distinct endotypes or phenotypes, it may not fully capture the diversity of these reactions. Our findings suggest a need for further research to refine this classification system and better accommodate patients with atypical presentations.

31 October 2023 in Thoracic Research and Practice
Verified
Journal Article
Open access
GCGulfem Elif Celik
Gulfem Elif Celik
OAOmur Aydin
Omur Aydin
EDEbru Damadoglu
Ebru Damadoglu
ABAyse Baccioglu
Ayse Baccioglu
SOSecil Kepil Ozdemir
Secil Kepil Ozdemir
AYArzu Yorgancioglu
Arzu Yorgancioglu
Asthma,long-term management,reliever,controller,severe asthma

11 January 2019 in Allergy
Verified
Journal Article
Closed access
PDF file
SÖSeçil Kepil Özdemir
Seçil Kepil Özdemir
AGAslı Gelincik
Aslı Gelincik
NPNail Paksoy
Nail Paksoy
GBGözde Köycü Buhari
Gözde Köycü Buhari
FEFerda Öner Erkekol
Ferda Öner Erkekol
SBSevim Bavbek
Sevim Bavbek